R&D stands for research and development, the process by which companies and governments invest time and money into creating new products, services, or knowledge. It’s the work that happens before something hits the market: discovering how things work, figuring out how to apply that knowledge, and building prototypes until a viable product emerges. Globally, countries pour trillions of dollars into R&D each year, with South Korea leading in intensity at nearly 5% of its entire economic output.
The Three Types of R&D
R&D breaks down into three distinct categories, each with a different goal and time horizon.
Basic research is the most open-ended. It’s theoretical or experimental work aimed purely at understanding how something works, with no specific product or application in mind. A university lab studying how cells communicate or how a particular material behaves under extreme heat is doing basic research. The payoff is uncertain and often years away, but it lays the groundwork for everything else.
Applied research takes that foundational knowledge and points it at a specific problem. A pharmaceutical company investigating whether a certain molecule can treat a disease is doing applied research. The goal is still to learn something new, but there’s a practical target in sight.
Experimental development is the most concrete stage. It draws on knowledge from research and hands-on experience to actually build something: designing prototypes, testing new manufacturing processes, or improving an existing product. This is where ideas start becoming real.
How Research Differs From Development
The “R” and the “D” in R&D serve fundamentally different purposes. Research (both basic and applied) is about acquiring new knowledge. Its defining characteristic is uncertainty. You don’t know what you’ll find, and many research paths lead nowhere. Development, by contrast, takes what’s already been learned and translates it into a plan, a design, or a working prototype. The risk profile shifts from “Will we discover anything useful?” to “Can we turn this into something that works reliably?”
In practice, the line between the two isn’t always clean. A team developing a new battery chemistry might bounce back and forth between applied research and experimental development as they encounter unexpected problems. But the general flow moves from discovery toward commercialization, with research feeding into development rather than the other way around.
From Idea to Market
R&D is the first phase of what’s sometimes called the technology life cycle. A company identifies a problem or opportunity, begins researching potential solutions, and works to develop a product. That product then enters the market, where sales rise as customers adopt it. Over time, competitors introduce alternatives, profits decline, and the cycle pushes the company back into R&D to improve its offering or create something new.
The timeline varies enormously. A software company might cycle through R&D in months. A pharmaceutical company developing a new drug could spend a decade or more before generating any revenue. How long a company is willing to invest depends largely on how confident it is that the resulting product will eventually generate enough sales to recoup those costs, a calculation known as commercial viability.
This is why R&D is inherently a bet on the future. Companies spend money now, with no guarantee of a return, hoping that the knowledge and products they develop will pay off later.
Who Spends the Most on R&D
The United States has the highest total R&D expenditure in the world, spending the equivalent of 3.46% of its GDP in 2021. But several smaller economies outpace it in R&D intensity, meaning they dedicate a larger share of their economic output to research and development. South Korea leads at 4.93%, followed by Taiwan at 3.77%. Japan (3.30%), Germany (3.13%), and the United Kingdom (2.91%) round out the top performers among major economies.
China’s trajectory is especially notable. In 2000, it spent just 0.89% of its GDP on R&D. By 2021, that figure had nearly tripled to 2.43%, reflecting a massive national push to become a global innovation leader. France, by comparison, moved from 2.09% to 2.22% over the same period, a much more modest increase.
Open vs. Closed Innovation Models
Traditionally, R&D happened behind closed doors. A company would staff its own labs, develop its own ideas in secret, and bring finished products to market. Apple under Steve Jobs was a well-known example of this closed model: hierarchical, secretive, and vertically integrated. The company controlled everything from software to hardware, and the result was transformative products like the iPhone.
The alternative is open innovation, where companies draw on ideas, talent, and technology from outside their walls. Google famously embraced this approach with its flat structure, employee autonomy (including the well-known “20% time” for personal projects), and open platforms like Android and Chrome. Rather than guarding every idea, open innovation assumes that the reduced cost and broader sourcing of ideas often outweigh the risks of giving up competitive secrecy.
Most companies today land somewhere between these extremes, keeping their most sensitive work internal while collaborating with universities, startups, or even competitors on less proprietary projects.
How Companies Measure R&D Success
Because R&D is expensive and uncertain, companies track specific metrics to gauge whether their investment is paying off. The most common ones fall into a few categories.
- Patents filed and granted: A rough indicator of how much novel work a company is producing. Patent counts alone don’t tell the whole story, though. A single high-value patent can matter more than dozens of incremental ones, so companies also track the quality and commercial impact of their patents.
- Revenue from new products: This measures the financial return on innovation directly. If a company spent heavily on R&D but new products aren’t contributing meaningfully to revenue, that signals a problem in either the research pipeline or the commercialization process.
- New product success rate: The percentage of development projects that make it to market and perform well. A higher rate suggests the company is good at identifying real market needs and executing on them. A low rate may indicate too many speculative bets or poor execution during the development phase.
No single metric captures the full picture. Patents measure output, revenue measures impact, and success rates measure efficiency. Companies typically track all three alongside internal benchmarks tailored to their industry.
R&D Tax Credits
In the United States, the federal government offers tax credits to encourage businesses to invest in R&D. To qualify, an activity has to pass a four-part test: the work must be technological in nature, intended to develop a new or improved product or process, involve a process of experimentation, and the associated costs must be eligible as research expenses under the tax code.
This means R&D tax credits aren’t limited to lab scientists in white coats. A manufacturer experimenting with a new production technique, a software company building a novel algorithm, or an engineering firm testing new materials can all potentially qualify. The credit is designed to offset some of the financial risk that comes with innovation, making it easier for companies of all sizes to invest in their future rather than playing it safe with existing products.